New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
DOI: | 10.6061/clinics/2017(06)10 |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/134126 |
Resumo: | OBJECTIVES: Transcription Factor 21 represses steroidogenic factor 1, a nuclear receptor required for gonadal development, sex determination and the regulation of adrenogonadal steroidogenesis. The aim of this study was to investigate whether silencing or overexpression of the gene Transcription Factor 21 could modulate the gene and protein expression of steroidogenic factor 1 in adrenocortical tumors. METHODS: We analyzed the gene expression of steroidogenic factor 1 using qPCR after silencing endogenous Transcription Factor 21 in pediatric adrenal adenoma-T7 cells through small interfering RNA. In addition, using overexpression of Transcription Factor 21 in human adrenocortical carcinoma cells, we analyzed the protein expression of steroidogenic factor 1 using Western blotting. RESULTS: Transcription Factor 21 knockdown increased the mRNA expression of steroidogenic factor 1 by 5.97-fold in pediatric adrenal adenoma-T7 cells. Additionally, Transcription Factor 21 overexpression inhibited the protein expression of steroidogenic factor 1 by 0.41-fold and 0.64-fold in two different adult adrenocortical carcinoma cell cultures, H295R and T36, respectively. CONCLUSIONS: Transcription Factor 21 is downregulated in adrenocortical carcinoma cells. Taken together, these findings support the hypothesis that Transcription Factor 21 is a regulator of steroidogenic factor 1 and is a tumor suppressor gene in pediatric and adult adrenocortical tumors. |
id |
USP-19_b2bd566a450f1ae54005dfc5576366e9 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/134126 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
spelling |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cellsTCF21POD1SF-1siRNA-POD1Adrenocortical Tumor CellsOBJECTIVES: Transcription Factor 21 represses steroidogenic factor 1, a nuclear receptor required for gonadal development, sex determination and the regulation of adrenogonadal steroidogenesis. The aim of this study was to investigate whether silencing or overexpression of the gene Transcription Factor 21 could modulate the gene and protein expression of steroidogenic factor 1 in adrenocortical tumors. METHODS: We analyzed the gene expression of steroidogenic factor 1 using qPCR after silencing endogenous Transcription Factor 21 in pediatric adrenal adenoma-T7 cells through small interfering RNA. In addition, using overexpression of Transcription Factor 21 in human adrenocortical carcinoma cells, we analyzed the protein expression of steroidogenic factor 1 using Western blotting. RESULTS: Transcription Factor 21 knockdown increased the mRNA expression of steroidogenic factor 1 by 5.97-fold in pediatric adrenal adenoma-T7 cells. Additionally, Transcription Factor 21 overexpression inhibited the protein expression of steroidogenic factor 1 by 0.41-fold and 0.64-fold in two different adult adrenocortical carcinoma cell cultures, H295R and T36, respectively. CONCLUSIONS: Transcription Factor 21 is downregulated in adrenocortical carcinoma cells. Taken together, these findings support the hypothesis that Transcription Factor 21 is a regulator of steroidogenic factor 1 and is a tumor suppressor gene in pediatric and adult adrenocortical tumors.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2017-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/13412610.6061/clinics/2017(06)10Clinics; Vol. 72 No. 6 (2017); 391-394Clinics; v. 72 n. 6 (2017); 391-394Clinics; Vol. 72 Núm. 6 (2017); 391-3941980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/134126/129937Copyright (c) 2017 Clinicsinfo:eu-repo/semantics/openAccessFrança, Monica MalheirosLerario, Antonio M.Fragoso, Maria Candida B.V.Lotfi, Claudimara Ferini Pacicco2017-06-29T12:15:35Zoai:revistas.usp.br:article/134126Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2017-06-29T12:15:35Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
title |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
spellingShingle |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells França, Monica Malheiros TCF21 POD1 SF-1 siRNA-POD1 Adrenocortical Tumor Cells França, Monica Malheiros TCF21 POD1 SF-1 siRNA-POD1 Adrenocortical Tumor Cells |
title_short |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
title_full |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
title_fullStr |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
title_full_unstemmed |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
title_sort |
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells |
author |
França, Monica Malheiros |
author_facet |
França, Monica Malheiros França, Monica Malheiros Lerario, Antonio M. Fragoso, Maria Candida B.V. Lotfi, Claudimara Ferini Pacicco Lerario, Antonio M. Fragoso, Maria Candida B.V. Lotfi, Claudimara Ferini Pacicco |
author_role |
author |
author2 |
Lerario, Antonio M. Fragoso, Maria Candida B.V. Lotfi, Claudimara Ferini Pacicco |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
França, Monica Malheiros Lerario, Antonio M. Fragoso, Maria Candida B.V. Lotfi, Claudimara Ferini Pacicco |
dc.subject.por.fl_str_mv |
TCF21 POD1 SF-1 siRNA-POD1 Adrenocortical Tumor Cells |
topic |
TCF21 POD1 SF-1 siRNA-POD1 Adrenocortical Tumor Cells |
description |
OBJECTIVES: Transcription Factor 21 represses steroidogenic factor 1, a nuclear receptor required for gonadal development, sex determination and the regulation of adrenogonadal steroidogenesis. The aim of this study was to investigate whether silencing or overexpression of the gene Transcription Factor 21 could modulate the gene and protein expression of steroidogenic factor 1 in adrenocortical tumors. METHODS: We analyzed the gene expression of steroidogenic factor 1 using qPCR after silencing endogenous Transcription Factor 21 in pediatric adrenal adenoma-T7 cells through small interfering RNA. In addition, using overexpression of Transcription Factor 21 in human adrenocortical carcinoma cells, we analyzed the protein expression of steroidogenic factor 1 using Western blotting. RESULTS: Transcription Factor 21 knockdown increased the mRNA expression of steroidogenic factor 1 by 5.97-fold in pediatric adrenal adenoma-T7 cells. Additionally, Transcription Factor 21 overexpression inhibited the protein expression of steroidogenic factor 1 by 0.41-fold and 0.64-fold in two different adult adrenocortical carcinoma cell cultures, H295R and T36, respectively. CONCLUSIONS: Transcription Factor 21 is downregulated in adrenocortical carcinoma cells. Taken together, these findings support the hypothesis that Transcription Factor 21 is a regulator of steroidogenic factor 1 and is a tumor suppressor gene in pediatric and adult adrenocortical tumors. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/134126 10.6061/clinics/2017(06)10 |
url |
https://www.revistas.usp.br/clinics/article/view/134126 |
identifier_str_mv |
10.6061/clinics/2017(06)10 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/134126/129937 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2017 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2017 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 72 No. 6 (2017); 391-394 Clinics; v. 72 n. 6 (2017); 391-394 Clinics; Vol. 72 Núm. 6 (2017); 391-394 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1822181677751861248 |
dc.identifier.doi.none.fl_str_mv |
10.6061/clinics/2017(06)10 |